PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 215 filers reported holding PDL BIOPHARMA INC in Q3 2015. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $210,000 | +4.0% | 66,592 | -4.2% | 0.00% | 0.0% |
| Q2 2020 | $202,000 | +7.4% | 69,520 | +4.2% | 0.00% | 0.0% |
| Q1 2020 | $188,000 | -17.9% | 66,692 | -5.5% | 0.00% | 0.0% |
| Q4 2019 | $229,000 | +48.7% | 70,546 | -0.8% | 0.00% | 0.0% |
| Q3 2019 | $154,000 | -35.3% | 71,140 | -6.0% | 0.00% | 0.0% |
| Q2 2019 | $238,000 | -30.0% | 75,683 | -17.2% | 0.00% | 0.0% |
| Q1 2019 | $340,000 | +24.1% | 91,418 | -3.1% | 0.00% | 0.0% |
| Q4 2018 | $274,000 | +9.6% | 94,380 | -0.8% | 0.00% | 0.0% |
| Q3 2018 | $250,000 | +10.6% | 95,106 | -1.7% | 0.00% | 0.0% |
| Q2 2018 | $226,000 | -21.3% | 96,759 | -0.7% | 0.00% | 0.0% |
| Q1 2018 | $287,000 | +2.1% | 97,463 | -5.1% | 0.00% | 0.0% |
| Q4 2017 | $281,000 | -22.2% | 102,705 | -3.7% | 0.00% | 0.0% |
| Q3 2017 | $361,000 | +48.0% | 106,622 | +8.1% | 0.00% | 0.0% |
| Q2 2017 | $244,000 | +5.6% | 98,650 | -3.0% | 0.00% | 0.0% |
| Q1 2017 | $231,000 | -71.5% | 101,739 | -73.4% | 0.00% | -66.7% |
| Q4 2016 | $810,000 | -99.9% | 382,262 | -2.1% | 0.00% | -40.0% |
| Q3 2016 | $1,308,121,000 | +5.7% | 390,484 | -0.9% | 0.01% | 0.0% |
| Q2 2016 | $1,237,314,000 | -6.8% | 394,049 | -1.1% | 0.01% | 0.0% |
| Q1 2016 | $1,327,000,000 | +283.5% | 398,357 | +307.4% | 0.01% | +400.0% |
| Q4 2015 | $346,000,000 | +66183.5% | 97,788 | -6.1% | 0.00% | -50.0% |
| Q3 2015 | $522,000 | -99.9% | 104,095 | -3.9% | 0.00% | -33.3% |
| Q2 2015 | $696,594,000 | -59.1% | 108,335 | -55.2% | 0.00% | -57.1% |
| Q1 2015 | $1,701,802,000 | -38.3% | 241,905 | -32.4% | 0.01% | -41.7% |
| Q4 2014 | $2,758,336,000 | +37.5% | 357,761 | +33.2% | 0.01% | +33.3% |
| Q3 2014 | $2,005,904,000 | -17.5% | 268,528 | +7.0% | 0.01% | -18.2% |
| Q2 2014 | $2,430,204,000 | +111.9% | 251,054 | +81.9% | 0.01% | +120.0% |
| Q1 2014 | $1,147,070,000 | -1.2% | 138,035 | +0.4% | 0.01% | -16.7% |
| Q4 2013 | $1,160,424,000 | +37.9% | 137,491 | +30.2% | 0.01% | +20.0% |
| Q3 2013 | $841,393,000 | +1.4% | 105,570 | -1.7% | 0.01% | 0.0% |
| Q2 2013 | $829,491,000 | – | 107,447 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Chapters Capital Management LLC | 119,700 | $254,000 | 0.43% |
| GSA CAPITAL PARTNERS LLP | 1,587,756 | $3,366,000 | 0.20% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 60,901 | $129,110,000 | 0.14% |
| Acrospire Investment Management LLC | 129,480 | $274,000 | 0.11% |
| SECOR Capital Advisors, LP | 410,323 | $870,000 | 0.11% |
| RBF Capital, LLC | 251,421 | $540,000 | 0.08% |
| Park West Asset Management LLC | 400,000 | $848,000 | 0.07% |
| MACKENZIE FINANCIAL CORP | 4,687,825 | $9,938,000 | 0.06% |
| CIGNA INVESTMENTS INC /NEW | 261,533 | $554,000,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 5,503,285 | $11,665,000 | 0.06% |